News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the schedule of Earnings Call to be held on November 11 2024 at 8:30 AM (IST) on Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2024.


दूसरी कैटेगरी